Navigation Links
ALCiS(R) Daily Relief Now Available at Walgreens
Date:4/8/2008

Fast-acting topical pain reliever lands its first national retail drug

chain

SAN JOSE, Calif., April 8, 2008 /PRNewswire/ -- ALCiS Health, Inc., a provider of patented pain relief products, today announced that Walgreens, the nation's largest drugstore chain, is stocking its over-the-counter topical pain relief cream, ALCiS Daily Relief, at all of its 6,237 stores. Its introduction onto Walgreens' shelves across the United States marks the product's first national retail drug store account.

Brian Berchtold, president and CEO of ALCiS Health said, "I'm pleased with the reception ALCiS Daily Relief is getting by consumers and health care professionals alike."

Since its inception in 2004, ALCiS has focused on a sampling and educational program for health care professionals to help establish the ALCiS brand and demonstrate the product's efficacy to the medical community. Over 5,000 medical professionals, including pain specialists, rheumatologists, orthopedic surgeons and family practitioners, participate in the ALCiS sampling program.

"My patients who have used ALCiS Daily Relief have told me that they love this product," said Lonnie Zeltzer, MD, Director, Pediatric Pain Program, David Geffen School of Medicine at UCLA. "It's not messy, it's easy to use, and it relieves sore muscles."

ALCiS Daily Relief is a pleasantly scented, topical pain reliever that appeals to those consumers that retailers like Walgreens target everyday, particularly female baby boomers.

Including Walgreens, ALCiS Daily Relief can now be found on shelves at 8,200 retail stores including regional drugstore chains Duane Reade throughout the New York tri-state area, Longs Drugs in California and Nevada, and a host of other retail drugstore chains, as well as a select number of specialty sports retail stores.

About ALCiS Daily Relief

The innovative, advanced patented technology found in ALCiS Daily Relief pain cream provides relief from pain in as little as five minutes. The medicines are delivered without skin irritation -- no hot or cold sensation, just fast-acting pain relief. It can be used for the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, and bruises, as well as back pain, neck pain, shoulder pain, foot pain, sore muscles, stiff joints and sports injuries. In addition, it can be used before and/or after any level of physical activity. For more information on where to find ALCiS Daily Relief, visit http://www.alcis.com/locator/

About ALCiS Health

ALCiS Health, Inc. (http://www.alcis.com), founded in 2004, and based in San Jose, California, markets innovative, patented pain relief products that address both the growing needs of athletic communities as well as the day-to-day needs of baby boomers. The company's products enable consumers to live more active and productive lives by providing temporary relief of aggravating aches and pains.


'/>"/>
SOURCE ALCiS Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
2. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
3. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
4. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
5. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
6. Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
7. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
8. BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
9. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
10. ValueRich Report on AMDL/China Available on Web Site
11. AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)...  Blueprint Bio, a company dedicated to identifying, protecting ... has closed its Series A funding round, according to ... "We have received a commitment from Forentis Fund that ... meet our current goals," stated Matthew Nunez . ... complete validation on the current projects in our pipeline, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):